News tagged with renal cell cancer
Anti-aging hormone Klotho inhibits renal fibrosis, cancer growth
A natural hormone known to inhibit aging can also protect kidneys against renal fibrosis, UT Southwestern Medical Center researchers have demonstrated.
Apr 13, 2011 |
5 / 5 (1) |
0
Everolimus improves progression-free survival for patients with rare pancreatic cancer
In an international Phase III randomized study, everolimus, an inhibitor of the mammalian target of rapamycin (mTOR), has shown to dramatically improve progression-free survival for patients with advanced pancreatic neuroendocrine ...
Feb 09, 2011 |
5 / 5 (1) |
0
Cancer drug used in combination with other therapies associated with increased risk of death
An analysis of previous studies indicates that compared with chemotherapy alone, use of the cancer drug bevacizumab in combination with chemotherapy or biological therapy is associated with an increased risk of treatment-related ...
Feb 01, 2011 |
not rated yet |
0
Novel therapy for metastatic kidney cancer developed
Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill ...
Dec 15, 2010 |
not rated yet |
0
URMC discovers new trigger for kidney cancer's invasive behavior
(PhysOrg.com) -- Scientists have unlocked a strong interaction between two proteins involved in kidney cancer that help to explain the menacing invasiveness of this particular disease, according to a University of Rochester ...
Oct 07, 2010 |
not rated yet |
0
Ablation proved as effective as traditional surgery in treating kidney cancer
A minimally invasive technique used to destroy kidney tumors with an electrically controlled heating probe showed similar effectiveness as surgical removal of tumors in curbing cancer recurrence rates for up to five years ...
Jun 02, 2010 |
not rated yet |
0
Study identifies surgical means for improving kidney cancer survival
When kidney cancer spreads to other body parts, patients usually receive a poor prognosis. A new Mayo Clinic study examined the benefits of surgical treatment of kidney cancer, specifically renal cell carcinoma, and how patients ...
Jun 02, 2010 |
not rated yet |
0
New tool for pre-surgical detection of kidney cancers may help patients avoid unnecessary surgeries
Kidney cancer is a radiographic diagnosis which means treatment decisions are often made based on the findings of a solid mass on CT or MRI. Unfortunately these tests cannot distinguish the different types of kidney cancers ...
Jun 01, 2010 |
5 / 5 (1) |
0
Researchers find papillary renal cell carcinoma unresponsive to sunitinib
Of the more than 38,000 Americans diagnosed with renal cell carcinoma (RCC) each year, approximately 20 percent have non-clear cell forms of the disease. New findings shows that a non-clear cell form of kidney cancer known ...
May 28, 2010 |
not rated yet |
0
Researchers find gene they believe is key to kidney cancer
Researchers at Mayo Clinic's campus in Florida have discovered a key gene that, when turned off, promotes the development of common kidney cancer. Their findings suggest that a combination of agents now being tested in other ...
May 20, 2010 |
not rated yet |
0
Researchers find genetic secrets to common kidney cancer
By examining expression of every human gene in clear cell renal cell carcinoma (ccRCC) compared to normal kidney cells, researchers at Mayo Clinic's campus in Florida have discovered gene signatures they say explain much ...
May 18, 2010 |
not rated yet |
0
Milk and risk of renal cell cancer: Genetic research sheds new light
While previous research had suggested that drinking milk was related to factors that may increase the risk of renal cell cancer, results of a recent study exploiting the genetic contribution to variation in milk consumption ...
May 06, 2010 |
5 / 5 (1) |
3
New findings may help patients with deadly kidney cancer
Van Andel Research Institute (VARI) researchers have found a way to reverse resistance to sunitinib, a treatment that is currently the first line of defense against clear cell renal cell carcinoma (ccRCC), a deadly form of ...
Feb 18, 2010 |
not rated yet |
0
Promising results shown for kidney cancer drug
The drug pazopanib (Votrient) slowed the progression of advanced renal cell carcinoma (RCC), a form of kidney cancer, in patients by 54% percent, according to a new study published in the Journal of Clinical Oncology.
Feb 04, 2010 |
not rated yet |
0
Mutations in the genome regulation machinery identified in clear cell renal cell carcinoma
In a new study, scientists have searched for mutations in the gene regions of more than 100 kidney cancer samples, the largest number of samples from a single tumour type to be sequenced to date.
Jan 06, 2010 |
5 / 5 (1) |
0
|
